The role of general practice pharmacists in supporting medicines use by people living with dementia
Not stated
- Funding
- Self-Funded PhD Students Only
- Application deadline
- Year-round applications
About the project
About the Project Medicines are a cornerstone of chronic disease management, including for people living with dementia (PLWD), who frequently experience polypharmacy and complex medication regimens. These challenges are particularly acute for community-dwelling PLWD, especially those without regular carer support. Inappropriate prescribing and poor adherence can lead to adverse outcomes such as falls, hospitalisation and increased treatment burden. Despite this, there remains a significant evidence gap in effective medicines management interventions for this population within primary care. Previous research has resulted in the development of an intervention to support medicines use by people living with dementia; however, this work was undertaken before the widespread implementation of pharmacists in general practices. This project will use a mixed methods approach to explore the role that general practice pharmacists currently play in supporting medicines use by people living with dementia; the findings from this project may inform the adaptation of the existing intervention. The successful candidate will develop skills in both quantitative and qualitative methodologies, which are widely used in health services research. Training that will be provided through the research project The successful candidate will receive training in relevant quantitative and qualitative methodologies and other generic research skills, such as delivering presentations, scientific writing/writing for publication, and time management. Expected impact activities This project will provide a clearer and more up-to-date understanding of the role that general practice pharmacists play alongside other primary health care professionals in supporting medicines use by people living with dementia. Findings from this work will be used to optimise medicines use for people living with dementia, to positively impact patient outcomes and quality of life.